BRAF V600E Mutant Metastatic Colorectal Cancer: New Treatment Options and Future Perspectives - European Medical Journal

BRAF V600E Mutant Metastatic Colorectal Cancer: New Treatment Options and Future Perspectives

Oncology

Watch this webinar on BRAF V600E mutant metastatic colorectal cancer (mCRC), chaired by therapeutic leaders in the field Professor Fortunato Ciardiello and Professor Chaira Cremolini.

The learning objectives of this webinar are to:

  • Understand how mCRC is a heterogeneous disease and the importance of mutation testing in this setting
  • Understand mCRC management guidelines and the implications on clinical practice
  • Review recent real-world data for patients with BRAF V600E mutant mCRC
  • Discuss the practical clinical management of patients with BRAF V600E mutant mCRC

This webinar is intended for audiences outside the UK only. Unrestricted funding for this medical education has been provided by Pierre Fabre

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given